Discordant results of tests for tuberculosis reconsidered - Authors' reply.

Autor: Ho CS; US Embassy, Panchsheel Marg, Shantipath, Chanakyapuri, New Delhi, Delhi 110021, India; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: gtb9@cdc.gov., Feng PJ; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Narita M; TB Control Program, Public Health-Seattle and King County, Seattle, WA, USA., Stout JE; Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC, USA., Chen M; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Pascopella L; Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, USA., Garfein R; Division of Global Public Health, School of Medicine, University of California, San Diego, CA, USA., Reves R; Denver Health and Hospital Authority, Denver, CO, USA., Katz DJ; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jazyk: angličtina
Zdroj: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Feb; Vol. 22 (2), pp. 164-165.
DOI: 10.1016/S1473-3099(21)00805-7
Abstrakt: Competing Interests: We declare no competing interests.
Databáze: MEDLINE